2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The standard evaluation of multisystem Langerhans cell histiocytosis (LCH) includes a clinical evaluation, laboratory tests and a skeleton/skull X-ray survey, with chest high-resolution computed tomography (HRCT) in the case of pulmonary involvement. Preliminary reports suggest that 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) may be useful for evaluating patients with LCH.

          Related collections

          Author and article information

          Journal
          Eur. J. Nucl. Med. Mol. Imaging
          European journal of nuclear medicine and molecular imaging
          Springer Nature America, Inc
          1619-7089
          1619-7070
          Apr 2017
          : 44
          : 4
          Affiliations
          [1 ] Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
          [2 ] Centre National de Référence de l'Histiocytose Langerhansienne, Service de Pneumologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
          [3 ] Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
          [4 ] Service de Radiologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
          [5 ] Service de Biostatistique et Information Médicale, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
          [6 ] U1153 CRESS, Biostatistics and Clinical Epidemiology Research Team, Paris, France.
          [7 ] Université Paris Diderot, Sorbonne Paris Cité, Paris, France. abdellatif.tazi@aphp.fr.
          [8 ] Centre National de Référence de l'Histiocytose Langerhansienne, Service de Pneumologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France. abdellatif.tazi@aphp.fr.
          [9 ] U1153 CRESS, Biostatistics and Clinical Epidemiology Research Team, Paris, France. abdellatif.tazi@aphp.fr.
          Article
          10.1007/s00259-016-3521-3
          10.1007/s00259-016-3521-3
          27645693
          3b01c12c-510f-4236-9031-fb0854d77e2e
          History

          Response to treatment,Langerhans cell histiocytosis,Management,PET-CT

          Comments

          Comment on this article